Benorilate

From Self-sufficiency
Revision as of 21:22, 29 July 2010 by PotatoBot (Talk) (Stub sorting and placement of stub template(s): musculoskeletal-drug-, analgesic-stub)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Benorilate
File:Benorilate.svg
Systematic (IUPAC) name
4-(acetylamino)phenyl 2-(acetyloxy)benzoate
Clinical data
Routes of
administration
Oral
Identifiers
CAS Number 5003-48-5
ATC code N02BA10 (WHO)
PubChem CID 21102
Chemical data
Formula C17H15NO5
Molar mass 313.305 g/mol[[Script error: No such module "String".]]
Script error: No such module "collapsible list".
  (verify)
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Benorilate (INN), or benorylate, is a ester-linked codrug of aspirin with paracetamol. It is used as an anti-inflammatory and antipyretic medication. In the treatment of childhood fever, it has been shown to be inferior to paracetamol and aspirin taken separately. In addition, because it is converted to aspirin, benorylate is not recommended in children due to concerns about Reye syndrome.[1]

References

  1. Simila S, Keinanen S, Kouvalainen K.Oral antipyretic therapy: evaluation of benorylate, an ester of acetylsalicylic acid and paracetamol. Eur J Pediatr. 1975 Dec 9;121(1):15-20. PMID 2478



es:Benorilato

ro:Benorilat vi:Benorylate